MedTrace Logo

Pharmacokinetic of Posaconazole in Critically Ill Patients

NCT05275179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-11-08

No results posted yet for this study

Summary

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.

Conditions

  • Therapeutic Drug Monitoring
  • Critical Illness

Interventions

OTHER

Posaconazole Therapeutic Drug Monitoring

Therapeutic Drug Monitoring is performed by measuring posaconazole concentrations in serum on seven consecutive days (anticipated).

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Dominic Wichmann, Prof · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2022-03-30
Completion
2022-11-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05275179 on ClinicalTrials.gov